MIND MEDICINE (MINDMED) INC.

Profile

Company Names

MIND MEDICINE (MINDMED) INC.

Addresses

ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY 10007

1166 ALBERNI STREET, SUITE 1604, VANCOUVER, A1 V6E 3Z3

1166 ALBERNI STEET, SUITE 1604, VANCOUVER, A1 V6E 3Z3

Phone Numbers

212-220-6633
(212) 220-6633

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$83,293,839.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2024-03-11 
$75,000,000.00 
$75,000,000.00 
$0.00 
Equity 
5
2023-08-11 
$7,000,000.00 
$7,000,000.00 
$0.00 
Equity 
4
2021-01-06 
$499,618.00 
$826,073.00 
$326,455.00 
Equity 
3
2020-12-11 
$78,268.00 
$128,730.00 
$50,462.00 
Equity 
2
2020-10-30 
$247,705.00 
$412,842.00 
$165,137.00 
Equity 
1
2020-05-22 
$468,248.00 
$468,248.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BARROW 
DIRECTOR, EXECUTIVE OFFICER
ROGER 
 
CRYSTAL 
DIRECTOR
STANLEY 
 
GLICK 
DIRECTOR
SCHOND 
 
GREENWAY 
EXECUTIVE OFFICER
STEPHEN 
 
HURST 
EXECUTIVE OFFICER, DIRECTOR
DANIEL 
 
KARLIN 
EXECUTIVE OFFICER
ANDREAS 
 
KREBS 
DIRECTOR
CARRIE 
 
LIAO 
EXECUTIVE OFFICER
BRIGID 
 
MAKES 
DIRECTOR
JAMON 
ALEXANDER 
RAHN 
EXECUTIVE OFFICER, DIRECTOR
JAMON ALEXANDER 
 
RAHN 
EXECUTIVE OFFICER, DIRECTOR
MARK 
R. 
SULLIVAN 
EXECUTIVE OFFICER
CAROL 
A. 
VALLONE 
DIRECTOR
MIRI 
HALPERIN 
WERNLI 
EXECUTIVE OFFICER
MIRIAM 
HALPERIN 
WERNLI 
DIRECTOR, EXECUTIVE OFFICER
MIRIAM HALPERIN 
 
WERNLI 
EXECUTIVE OFFICER, DIRECTOR
MATT 
 
WILEY 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2023-08-11 
D
PHARMACEUTICALS 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Equity 
2024-03-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-11 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-05-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERLINK PARTNERS LLC
NONE
NONE
NONE
CANTOR FITZGERALD + CO.
134
NONE
NONE
RBC CAPITAL MARKETS, LLC